Back
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Vs. Korro Bio Industry Stock Comparison
Buy
79
DCF
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund
Last Price:
9.21
Seasonality Move:
4.42%
Sell
47
KRRO
Korro Bio
Last Price:
50.13
Seasonality Move:
51.42%
Buy
79
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund (DCF)
is a Buy
Is BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund a Buy, Sell or Hold?
- The current BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund [DCF] share price is $9.24. The Score for DCF is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- DCF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Korro Bio (KRRO)
is a Sell
Is Korro Bio a Buy, Sell or Hold?
- The current Korro Bio [KRRO] share price is $55.01. The Score for KRRO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- KRRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DCF Stock Price Chart
What is BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund's stock price today?
-
The BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund share price today is $9.24
The current trend is moderately bullish and DCF is experiencing slight buying pressure.
DCF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 59.28 | Buy |
| Chaikin Money Flow: | 11876 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.15 - 9.21) | Buy |
| Bollinger Bands (100): | (8.91 - 9.19) | Buy |
KRRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.92 | Buy |
| Relative Strength Index (14 RSI): | 44.75 | Sell |
| Chaikin Money Flow: | -239219 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.47 - 75.21) | Sell |
| Bollinger Bands (100): | (33.91 - 58.81) | Buy |
DCF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.21 | Buy |
| 20-day SMA: | 9.19 | Buy |
| 50-day SMA: | 9.17 | Buy |
| 200-day SMA: | 8.81 | Buy |
| 8-day EMA: | 9.21 | Buy |
| 20-day EMA: | 9.2 | Buy |
| 50-day EMA: | 9.15 | Buy |
| 200-day EMA: | 8.81 | Buy |
KRRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.77 | Sell |
| 20-day SMA: | 66.99 | Sell |
| 50-day SMA: | 49.78 | Buy |
| 200-day SMA: | 51.83 | Buy |
| 8-day EMA: | 64.4 | Sell |
| 20-day EMA: | 62.15 | Sell |
| 50-day EMA: | 54.74 | Buy |
| 200-day EMA: | 49.56 | Buy |
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Earnings Growth & DCF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Korro Bio Earnings Growth & KRRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.16 per share, and a decrease next year of $0.40 per share.
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Korro Bio Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||